ML11229A081

Lr Hearing - NIA-089

ML11229A081
Person / Time
Site:	Indian Point
Issue date:	10/29/2009
From:	Sandia
To:	Office of Nuclear Reactor Regulation
References
NIA-089
Download: ML11229A081 (6)

Text

NIA-089

• File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM

• DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'

• EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'

• ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.

• IPLUME - dispersion code option MIIPLUME001 2

• NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7

• IPRINT - amount of output desired MIIPRINT001 0

• POPFLG - is population uniform or defined by Site Data File.

PDPOPFLG001 FILE

• ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE.

MIORGDEF002 'A-RED MARR' .TRUE.

MIORGDEF003 A-LUNGS .TRUE.

MIORGDEF004 A-THYROIDH .TRUE.

MIORGDEF005 A-STOMACH .TRUE.

MIORGDEF006 'A-LOWER LI' .FALSE.

MIORGDEF007 L-EDEWBODY .TRUE.

MIORGDEF008 'L-RED MARR' .TRUE.

MIORGDEF009 'L-BONE SUR' .TRUE.

MIORGDEF010 L-BREAST .TRUE.

MIORGDEF011 L-LUNGS .TRUE.

MIORGDEF012 L-THYROID .TRUE.

MIORGDEF013 'L-LOWER LI' .TRUE.

MIORGDEF014 'L-BLAD WAL' .TRUE.

MIORGDEF015 L-LIVER .FALSE.

MIORGDEF016 L-THYROIDH .TRUE.

• RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.

• OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE.

NIA-089

• CSFACT - Cloudshine shielding factor SECSFACT001 1.

SECSFACT002 0.75 SECSFACT003 0.6

• PROTIN - Inhalation protection factor SEPROTIN001 1.

SEPROTIN002 0.41 SEPROTIN003 0.33

• BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4

• SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33

• GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2

• RESCON - Initial value for emergency-phase resuspension concentration factor.

SERESCON001 1.E-4

• RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.

SERESHAF001 1.82E5

• EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'

• WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE

• WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00

• LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0

• ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800.

• CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY

NIA-089

• TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.

• TIMNRM - Normal Relocation Time (Seconds from Plume Arrival)

SRTIMNRM001 86400.

• DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)

SRDOSHOT001 0.5

• DOSNRM - Normal Relocation Dose Threshold (Sieverts)

SRDOSNRM001 0.25

• NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2

• ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)

EFATAGRP001 'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0

• NUMEIN - Number of Early Injury Effects EINUMEIN001 7

• ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor.

EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1. .5 2. 3.

EINJUGRP002 DIARRHEA A-STOMACH 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS 1. 5. 10. 7.

EINJUGRP004 'SKIN ERYTHEMA' A-SKIN 1. 3. 6. 5.

EINJUGRP005 TRANSEPIDERMAL A-SKIN 1. 10. 20. 5.

EINJUGRP006 THYROIDITIS A-THYROIDH 1. 40. 240. 2.

EINJUGRP007 HYPOTHYROIDISM A-THYROIDH 1. 2. 60. 1.3

• NUMACA - number of latent cancer effects LCNUMACA001 7

• ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0

• DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2

• ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA 'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0

NIA-089 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0

• NUM1=0 TYPE1NUMBER 0

• NUM1 - Number of results of type 1 TYPE1NUMBER 4

• NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE

• NUM2=0 TYPE2NUMBER 0

• NUM3=0 TYPE3NUMBER 0

• NUM4=0 TYPE4NUMBER 0

• NUM4 - Number of results of type 4 TYPE4NUMBER 3

• I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE

• NUM5 =0 TYPE5NUMBER 0

• NUM5 - Number of results of type 5 TYPE5NUMBER 1

• NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE

• NUM6 =0 TYPE6NUMBER 0

• NUM7=0 TYPE7NUMBER 0

NIA-089

• NUM8=0 TYPE8NUMBER 0

• NUM8 - Number of results of type 8 TYPE8NUMBER 2

• NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE

• NUMA=0 TYPEANUMBER 0

• NUMB =0 TYPEBNUMBER 0

• NUMB - Number of results of type B TYPEBNUMBER 20

• NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE

• NUMC=0 TYPECNUMBER 0

• NUMD = 0 TYPEDNUMBER 0

NIA-089

• DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT

• KIMODL, KI model EZKIMODL001 NOKI

• EFFACY, KI Ingestion EZEFFACY001 0.

• POPFRAC, KI Ingestion EZPOPFRC001 0.

.